Photos from the CoolingCancer 5th Annual Golf Tournament were published in Midweek’s October 4, 2017 Edition of Honolulu Pa’ina. The publication gives further exposure to our non-profit charity organization and our purpose of contributing to the efforts of finding a cure for cancer. All photos are copyright of Tony Grillo.
UNIVERSITY OF HAWAII LEADS GROUNDBREAKING CANCER STUDY
Written by: Hawaii News Now, June 11, 2018Article: http://www.hawaiinewsnow.com/story/38395315/university-of-hawaii-leads-groundbreaking-cancer-study HONOLULU (AP) – The University of Hawaii Cancer Center is the leader in a groundbreaking national study that found that early-stage breast cancer patients with the most common form of the disease do not benefit from chemotherapy. The Honolulu Star-Advertiser reports the center helped develop the […]
CANCER PATIENT GIVEN JUST 3 MONTHS TO LIVE IS CURED BY EXPERIMENTAL TREATMENT
Written by: Alexandra Klausner, NY Post, June 6, 2018 | 10:12amArticle: https://nypost.com/2018/06/06/cancer-patient-given-just-3-months-to-live-is-cured-by-experimental-treatment/?utm_source=email_sitebuttons&utm_medium=site%20buttons&utm_campaign=site%20buttons Two and a half years ago, doctors told a Florida woman battling breast cancer that she had just three months to live. Judy Perkins, 52, of Port St. Lucie, is now cancer free thanks to an experimental treatment that harnessed billions of her […]
DR. CANCER RESEARCH
Written by: Susan Kang Sunderland, Midweek, December 5, 2017 @ 3:18pmArticle: http://www.midweek.com/dr-cancer-research/ One year after taking over as director of University of Hawai‘i Cancer Center, Dr. Randall Holcombe remains committed to finding cures and developing new methods of prevention in the ongoing fight against cancer. Class will come to order. Today’s lesson is on one […]
UH CANCER CENTER RESEARCHERS PICK UP PROVISIONAL PATENT FOR CANCER FINDING
Written by: Lorin Eleni Gill, Reporter for Pacific Business News, May 6, 2016 @ 2:19pm University of Hawaii Cancer Center researchers have secured a provisional patent that will assist in cancer research and potentially help doctors catch cancer earlier. Lana Garmire, an assistant professor in the Cancer Epidemiology Program, led the study using “big data,” […]
UH CANCER RESEARCHERS RECEIVE $3M FROM U.S. DEFENSE DEPARTMENT
Written by: Lorin Eleni Gill, Biz Journals, March 30, 2016 @ 12:29pm HST Researchers at the University of Hawaii Cancer Center and John A. Burns School of Medicine in Honolulu have been awarded $3 million by the Department of Defense for mesothelioma-related research projects. The cancer research grants, which focus on asbestos-related malignant mesothelioma, were […]
UH BLADDER CANCER DRUG SHOWS PROMISE
Written by: Kristen Consillio, Star Advertiser, November 23, 2015 @ 1:30am The University of Hawaii Cancer Center is a step closer to getting federal approval for a new bladder cancer drug. The drug, an interleukin 15 superagonist complex combined with Bacillus Calmette-Guerin, or BCG, currently in clinical trials, is expected to be more effective for […]
NEW KIND OF ‘DESIGNER’ IMMUNE CELLS CLEAR BABY’S LEUKEMIA
Written by: Kate Kelland, Reuters.com, November 6, 2015 @ 9:58am EST(http://www.reuters.com/article/2015/11/06/us-health-leukaemia-cellectis-idUSKCN0SU2PO20151106) A baby whom doctors thought almost certain to die has been cleared of a previously incurable leukemia in the first human use of an “off-the-shelf” cell therapy from Cellectis that creates designer immune cells. One-year-old Layla had run out of all other treatment options […]
NEW TREATMENT FOR MELANOMA GETS FDA APPROVAL
Written by: Robert Preidt, HealthDay.com, October 28, 2015(http://consumer.healthday.com/cancer-information-5/skin-cancer-news-108/novel-treatment-for-melanoma-shows-promise-in-early-trial-704669.html) A genetically engineered cold sore virus that “blows up” melanoma tumors has been approved by the U.S. Food and Drug Administration to help treat the deadly skin cancer. Imlygic (talimogene laherparepvec), a first-of-its-kind therapy, showed promise against lesions in the skin and lymph nodes in an early […]
NOVOCURE: TTFIELDS THERAPY
Novocure is a global, commercial-stage oncology company that is pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields, with the use of electric fields. Novocure is headquartered in Jersey Isle, and operates in Portsmouth, NH and New York, NY. The company also has offices in Switzerland, Germany and Japan, and a […]